Stewart J J, Agosto H, Litwin S, Welsh J D, Shlomchik M, Weigert M, Seiden P E
Department of Molecular Biology, Princeton University, NJ 08544, USA.
J Immunol. 1997 Aug 15;159(4):1728-38.
Rheumatoid factors (RF) associated with arthritic joint erosion are only seen transiently, if at all, in nondiseased individuals. Therefore, a tolerance mechanism must exist that prevents pathologic RF B cells from expressing Abs. Surprisingly, it has been shown that pathologic RF B cells are not tolerized by any previously established tolerance mechanism such as deletion, receptor editing, anergy, or prevention of memory establishment. How are pathologic RF cells tolerized? By simulating the RF response with a cellular automaton model immune system, we demonstrate that pathologic RFs can be tolerized by the novel mechanism of "competitive tolerance" with natural, nonpathologic RFs. We then demonstrate that competitive tolerance can be broken when a sequestered pool of expanding B cells are inappropriately subjected to chronic stimulation (as appears to occur in MRL/lpr mice and in patients with rheumatoid arthritis).
与关节炎性关节侵蚀相关的类风湿因子(RF)在非患病个体中即便出现也只是短暂的。因此,必然存在一种耐受机制来阻止病理性RF B细胞表达抗体。令人惊讶的是,已表明病理性RF B细胞并未通过任何先前确立的耐受机制(如缺失、受体编辑、无反应性或记忆形成的阻止)而产生耐受。病理性RF细胞是如何产生耐受的呢?通过用细胞自动机模型免疫系统模拟RF反应,我们证明病理性RF可通过与天然、非病理性RF的“竞争性耐受”这一新机制产生耐受。然后我们证明,当一群被隔离的正在扩增的B细胞不恰当地受到慢性刺激时(如在MRL/lpr小鼠和类风湿关节炎患者中似乎发生的那样),竞争性耐受会被打破。